期刊文献+

氟喹诺酮类药物体外诱导大肠埃希菌耐药性观察 被引量:10

Observation of Escherichia coli induced resistance to fluoroquinolones in vitro
下载PDF
导出
摘要 目的:探讨大肠埃希菌在氟喹诺酮类最低抑菌浓度(MIC)下耐药性的产生,以指导临床合理使用抗生素。方法:采用多步诱导法,对32株临床分离的氟喹诺酮类敏感大肠埃希菌分别进行环丙沙星、左氧氟沙星和加替沙星的诱导性耐药试验;用琼脂稀释法测定诱导前后敏感菌株的药物敏感性;用PCR方法测定耐药基因序列。结果:22株大肠埃希菌诱导出稳定的高耐氟喹诺酮菌株;与原株比较,耐药株的MIC分别增加了32~3000倍;进行测序的6株诱导耐药菌株均发生gyrA的83Ser→Leu、87Asp→Asn和parC的80Ser→Ile突变,而测序的1株敏感菌株未发现基因突变。结论:在低浓度抗菌药物的长期压力下,可诱导大肠埃希菌产生对氟喹诺酮类的获得性耐药。 Aim:To observe the induced resistance of Escherichia coli to a variety of fluoroquinolones in drug concentration of sub-MIC.Methods:The experiments on induced resistance to ciprofloxacin,levofloxacin or gatifloxacin were performed,in thrity-two Escherichia coli sensitived to fluoroquinolones from clinic,respectively,by multiple-step method.The susceptibility of the induced strains resistant to fluoroquinolones was measured by determining the MIC using agar dilution method.Results:The strains highly resistant to fluoroquinolone were obtained from 22 tested strain of Escherichia coli,the MICs of these laboratory resistant strains were with 32 to 3 000 fold increase,respectively,when compared with parent strains.All six induced highly resistant strains examined carried two gyrA mutations affecting residues 83Ser→Leu,Asp87→Asn and one parC mutation of 80Ser→Ile.No mutation was found in a susceptible isolate.Conclusion:Acquired resistance could be occurred when exposing to low level of some fluoroquinolones for long term.
作者 赵磊 荆鹏伟
出处 《郑州大学学报(医学版)》 CAS 北大核心 2011年第1期103-106,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 大肠埃希菌 氟喹诺酮类 诱导性耐药 体外 Escherichia coli fluoroquinolone induced resistance in vitro
  • 相关文献

参考文献12

  • 1Neuhauser MM, Weinstein RA, Rydman R,et al. Antibiot- ic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use [ J ]. JA- MA ,2003 ,289 (7) :885.
  • 2范柏.喹诺酮类抗菌药的作用机制及细菌耐药性的研究进展[J].国外医药(抗生素分册),2004,25(1):27-29. 被引量:67
  • 3Oram M, Fisher LM. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identi- fied by using the polymerase chain reaction [ J]. Antimi- crob Agents Chemother, 1991,35 (2) :387.
  • 4Heisig P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli [ J]. Antimicrob Agents Chemother, 1996, 40(4) :879.
  • 5余道军,童文娟,陈岳明,庄金凤.临床标本细菌基因组DNA提取方法探讨[J].中国微生态学杂志,2007,19(6):519-520. 被引量:38
  • 6Tankovic J,Bachoual R, Ouabdesselam S,et al. In-vitro activ- ity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis[J]. J Antimicrob Chemother, 1999,43 ( Suppl B) : 19.
  • 7Jacoby GA. Mechanisms of resistance to quinolones [ J ]. Clin Infect Dis, 2005,41 ( Suppl 2 ) : 120.
  • 8Hooper DC. Emerging mechanisms of fluoroquinolone re- sistance [ J ]. Emerg Infect Dis, 2001,7 (2) :337.
  • 9Yoshida H, Bogaki M, Nakamura M,et al. Quinolone re- sistance-determining region in the DNA gyrase gyrA gene of Escherichia coli[ J]. Antimicrob Agents Chemother,1990, 34(6) :1271.
  • 10Wang H, Dzink-fox JL, Chert M, et al. Genetic character- ization of highly fluoroquinolone-resistant clinical Esche- richia coli strains from China: role of acrR mutations[ J]. Antimicrob Agents Chemother,2001,45 ( 5 ) : 1515.

二级参考文献26

共引文献102

同被引文献103

引证文献10

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部